Boundless Bio Profit Margin

Boundless Bio's profit margin stands at -Infinity% as of March 2026. That is below the sector sector average of 19.72%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Boundless Bio sits lower the its sector benchmark (19.72%) with a profit margin of -Infinity%. That is roughly Infinity% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -Infinity% for Boundless Bio means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Boundless Bio's profit margin evolved across reporting periods, while the comparison chart places BOLD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.